Webinar: Evidence in Chinese patent enforcement: Key differences with the US

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Webinar: Evidence in Chinese patent enforcement: Key differences with the US

Sponsored by

purplevine-ip.png
MIP article page@4x.jpg

Join Ude Lu, the chief IP counsel (US) of Purplevine IP, Helen Zhang, the litigation manager of Purplevine IP in Beijing, and Penny Sun, the brand protection manager of ABRO Industry, as they discuss evidence collection for patent enforcement in China and the US virtually with Managing IP on November 9 at 10am (US ET) / 3pm (UK) / 11pm (China)

Register here to join Purplevine IP’s webinar: Evidence in Chinese patent enforcement: Key differences with the US.

China has become one of the most litigious countries for patent enforcement. Foreign patentees may therefore face challenges when collecting evidence in China because, unlike in most European countries and the US, the plaintiff has the burden of proof in proving infringements.

Foreign patentees should have well-planned patent enforcement strategies and be prepared for evidence collection when encountering lawsuits in China.

The webinar will focus on the differences between the Chinese and US approaches to infringement litigation in the following areas:

  • The types of evidence required;

  • The factual evidence needed; and

  • Evidence regarding the claim amount.

Join Purplevine IP’s experts as they compare evidence collection for patent litigation in China with the approach in the US.

Register here to join Purplevine IP’s webinar on November 9 2022.

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article